Jane Street’s SELLAS Life Sciences SLS Stock Holding History

Jane Street’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.5M	Buy	+508,429	New	+$3.51M	﹤0.01%	3179
2026 Q1	–	Sell	-59,536	Closed	-$266K	–	12877
2025 Q4	$224K	Sell	59,536 -43,423	-42%	-$84.4K	﹤0.01%	9494
2025 Q3	$166K	Buy	102,959 +56,277	+121%	+$100K	﹤0.01%	9811
2025 Q2	$102K	Sell	46,682 -11,859	-20%	-$18.2K	﹤0.01%	8939
2025 Q1	$63.2K	Buy	58,541 +46,237	+376%	+$54.9K	﹤0.01%	8949
2024 Q4	$12.8K	Buy	+12,304	New	+$14K	﹤0.01%	9164
2024 Q3	–	Sell	-27,994	Closed	-$34.2K	–	10337
2024 Q2	$33.3K	Buy	+27,994	New	+$38.1K	﹤0.01%	8990
2023 Q4	–	Sell	-11,032	Closed	-$18.1K	–	9749
2023 Q3	$18.1K	Buy	+11,032	New	+$17.4K	﹤0.01%	8317
2021 Q4	–	Sell	-20,367	Closed	-$154K	–	10763
2021 Q3	$186K	Buy	+20,367	New	+$189K	﹤0.01%	8905
2021 Q1	–	Sell	-19,363	Closed	-$112K	–	9543
2020 Q4	$112K	Buy	+19,363	New	+$77.5K	﹤0.01%	7176
2019 Q4	–	Sell	-1,671	Closed	-$10K	–	5686
2019 Q3	$10K	Buy	+1,671	New	+$12.3K	﹤0.01%	4971

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 374.31% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street's SLS Position: Q2 2026 in Review

Jane Street opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 508,429 shares worth $7.5M. The stake represents ﹤0.01% of the portfolio and ranks #3179 among its holdings. This is a return to the name: Jane Street previously reported a position in SLS as recently as Q4 2025.

Jane Street first reported a position in SLS in Q3 2019 and has held it in 11 quarters since. 189 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

Jane Street held 508,429 shares of SELLAS Life Sciences worth $7.5M as of Q2 2026.
SELLAS Life Sciences was a new Jane Street position in Q2 2026.
SELLAS Life Sciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #3179 holding.
Jane Street first reported a position in SELLAS Life Sciences in Q3 2019 and has held it in 11 quarters since.
189 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.